comprehensive -WSS

comprehensive

author：focus 2025-08-04 03:41:54 - browse：11

Illumina building. -- biotech coverage from STAT — Adobe

LONDON — The European Union on Wednesday issued an antitrust fine of $475 million to the U.S. genetic sequencing giant Illumina for closing its acquisition of cancer detection company Grail before clearing it with regulators.

The fine amounts to nearly 10% of Illumina’s annual global revenue, which is the most the European Commission can penalize a company under its merger regulations. The commission called Illumina’s actions “an unprecedented and very serious infringement” of the EU’s policies, including the “cornerstone” that regulators review deals that can alter the market.

The commission also issued what it called a symbolic fine of 1,000 Euros, or about $1,100, to Grail for what it said was the firm’s “active role” in the deal’s infringement of EU rules.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Cassava reveals details — and problems — with Alzheimer's study

WSS

CDC recommends rationing of RSV shot due to shortages

CDC recommends rationing of RSV shot due to shortages

WHO may add ‘noma' to its list of neglected tropical diseases

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Diversifying clinical trials isn't enough to close racial gaps: study

Readout Newsletter: New research from Sanofi, Regeneron, etc.

knowledge

comprehensive

focus

Affirmative action in medical school literally saved lives

Readout Newsletter: XBI biotech index, Akero Therapeutics

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Maker of FluMist seeks to allow at

State Dept. review finds Biden bears some blame for Afghanistan failures

The mammogram wars are not over

Psychedelics group wrestles with new pharma identity

Biden announces an advanced cancer research initiative

At least 13 dead in Texas as scorching temps continue

Maker of FluMist seeks to allow at

Wikipedia

Maker of FluMist seeks to allow at

'The boss' wants server deleted: New allegations emerge in Trump indictment

Biden announces an advanced cancer research initiative

The mammogram wars are not over

Readout Newsletter: What happened with Sarepta's Duchenne data

Maker of FluMist seeks to allow at

leisure time

explore

entertainment

focus